Canada markets closed

Eupraxia Pharmaceuticals Inc. (EPRX.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
3.5600-0.0400 (-1.11%)
At close: 03:58PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 128.24M
Enterprise Value 92.14M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.79
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -3.88

Trading Information

Stock Price History

Beta (5Y Monthly) 1.17
52-Week Change 3-52.88%
S&P500 52-Week Change 324.96%
52 Week High 39.1000
52 Week Low 33.4400
50-Day Moving Average 33.7883
200-Day Moving Average 35.3566

Share Statistics

Avg Vol (3 month) 334.64k
Avg Vol (10 day) 317.21k
Shares Outstanding 535.62M
Implied Shares Outstanding 635.62M
Float 829.91M
% Held by Insiders 16.93%
% Held by Institutions 111.89%
Shares Short (Jun 14, 2024) 410.96k
Short Ratio (Jun 14, 2024) 40.53
Short % of Float (Jun 14, 2024) 40.05%
Short % of Shares Outstanding (Jun 14, 2024) 40.03%
Shares Short (prior month May 15, 2024) 415.33k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-75.51%
Return on Equity (ttm)-267.25%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -30.89M
Net Income Avi to Common (ttm)-30.37M
Diluted EPS (ttm)-1.6400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)35.91M
Total Cash Per Share (mrq)1.01
Total Debt (mrq)9.56M
Total Debt/Equity (mrq)52.78%
Current Ratio (mrq)1.95
Book Value Per Share (mrq)0.55

Cash Flow Statement

Operating Cash Flow (ttm)-22.24M
Levered Free Cash Flow (ttm)-11.28M